Home/Filings/4/0001127602-24-013994
4//SEC Filing

Romanelli Joseph 4

Accession 0001127602-24-013994

CIK 0000310158other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:29 PM ET

Size

13.0 KB

Accession

0001127602-24-013994

Insider Transaction Report

Form 4
Period: 2024-04-30
Romanelli Joseph
President, Human Health Int?l
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-02$128.80/sh+2,262$291,34621,831.325 total
  • Award

    Restricted Stock Unit

    2024-04-30+6,1916,191 total
    From: 2025-04-30Exp: 2027-04-30Common Stock (6,191 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-022,2624,524 total
    From: 2024-05-02Exp: 2026-05-02Common Stock (2,262 underlying)
  • Tax Payment

    Common Stock

    2024-05-02$128.80/sh1,115$143,61220,716.325 total
  • Award

    Stock Option (Right to Buy)

    2024-04-30+23,43823,438 total
    Exercise: $129.22From: 2025-04-30Exp: 2034-04-29Common Stock (23,438 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
  • [F3]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
  • [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001938322

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:29 PM ET
Size
13.0 KB